Benzinga FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions. read more
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions. read more